The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Immunization: vital progress, unfinished agenda
Open accessAbstract
Vaccination against infectious diseases has changed the future of the human species, saving millions of lives every year, both children and adults, and providing major benefits to society as a whole. Here we show, however, that national and sub-national coverage of vaccination varies greatly and major unmet needs persist. Although scientific progress opens exciting perspectives in terms of new vaccines, the pathway from discovery to sustainable implementation can be long and difficult, from the financing, development and licensing to programme implementation and public acceptance. Immunization is one of the best investments in health and should remain a priority for research, industry, public health and society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune memory is the source of protective immunity from a subsequent infection (Orenstein and Ahmed, 2017; Piot et al., 2019; Plotkin et al., 2018).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Piot et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32203-7 · Cited by 8,600
Ten Great Public Health Achievements—United States, 1900-1999
(1999) · JAMA · doi:10.1001/jama.281.16.1481 · Cited by 1,313
Restrepo, A. M. H., Camacho, A., Longini, I. M., Watson, C., Edmunds, W. J., Egger, M., Carroll, M. W., Dean, N. E., Diatta, I. D., Doumbia, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32621-6 · Cited by 1,112
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
Sridhar, S., Luedtke, A. R., Langevin, E., Zhu, M., Bonaparte, M. I., Machabert, T., Savarino, S. J., Zambrano, B., Moureau, A., Khromava, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800820 · Cited by 792
The basic reproduction number (R0) of measles: a systematic review
Guerra, F. M., Bolotin, S., Lim, G. H., Heffernan, J. M., Deeks, S. L., Li, Y., & Crowcroft, N. S. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30307-9 · Cited by 713
Translational research: crossing the valley of death
Butler, D. (2008) · Nature · doi:10.1038/453840a · Cited by 712
Lane, S., MacDonald, N. E., Marti, M., & Dumolard, L. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.03.063 · Cited by 530
Economic burden of seasonal influenza in the United States
Putri, W. C. W. S., Muscatello, D. J., Stockwell, M. S., & Newall, A. T. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.05.057 · Cited by 493
Simply put: Vaccination saves lives
Orenstein, W. A., & Ahmed, R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704507114 · Cited by 449
The complexity and cost of vaccine manufacturing – An overview
Plotkin, S. A., Robinson, J. M., Cunningham, G., Iqbal, R., & Larsen, S. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.003 · Cited by 437
Research works printed but not linked: 3
- World Health Organization. Rubella vaccines: WHO position paper. Wkly. Epidemiol. Rec. 86, 301–316 (2011).
- World Health Organziation. Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 — conclusions and recommendations. Wkly. Epidemiol. Rec. 89, 221–236 (2014).
- Akanmori, B., Bellah, A., Ward, M. & Rago, L. The African vaccine regulatory forum (AVAREF): a platform for collaboration in a public health emergency. WHO Drug Inf. 29, 127–132 (2015).
Cited by
Sorted by citations
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790
“The vast majority of licensed human vaccines work on the basis of protective antibody responses, with neutralizing antibodies being the most common mechanism of action (Piot et al., 2019; Plotkin, 2010; Plotkin et al., 2018).”
Larson, H. J., Gakidou, E. E., & Murray, C. J. L. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2106441 · Cited by 516
Self-citationVaccine confidence in the time of COVID-19
Harrison, E. A., & Wu, J. W. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00634-3 · Cited by 477
Metadata
- Authors
- Piot, P., Larson, H. J., O’Brien, K. L., N’kengasong, J., Ng, E., Sow, S., & Kampmann, B.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- University of Antwerp (BE)
- World Health Organization (CH)
- Centre Pour le Développement des Vaccins-Mali (ML)
- Venue
- Nature
- Published
- 2019-11-06
- Volume
- 575
- Issue
- 7781
- Pages
- 119-129
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2985393490
- Cited by
- 206
- References
- 72
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 28 · 2023: 21 · 2022: 45 · 2021: 39 · 2020: 29
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Bill and Melinda Gates Foundation
- Pfizer
- World Health Organization
- Wellcome Trust
- UK Research and Innovation
- National Institute for Health and Care Research (SRF-2009-02-07)
- European Commission
- Medical Research Council (MR/R005990/1, MC_PC_17221, MR/R005990/2, MC_EX_MR/K011944/1, MC_EX_MR/P024270/1)
- Topics
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- immunization, vaccination, vaccination coverage, vaccine development, vaccine implementation, vaccine safety, vaccine financing, vaccine licensure, vaccine hesitancy, infectious disease prevention, public health investment
- MeSH terms
- Drug Development, Animals, Humans, Mortality, Philippines, Social Change, Vaccination, Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review